Sign up to save your podcasts
Or
Share Quickfire Updates From Chicago: What’s New for EGFR TKI Refractory and Resistant Non-Small Cell Lung Cancer?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Quickfire Updates From Chicago: What’s New for EGFR TKI Refractory and Resistant Non-Small Cell Lung Cancer?
Are you aware of the rapid progress for patients with epidermal growth factor receptor (EGFR) exon 20 insertion-mutated non-small cell lung cancer (NSCLC) and strategies for tackling osimertinib resistance? Credit available for this activity expires: [07/11/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976634?src=mkm_podcast_addon_976634
View all episodes
By Medscape Podcasts
4
77 ratings
Are you aware of the rapid progress for patients with epidermal growth factor receptor (EGFR) exon 20 insertion-mutated non-small cell lung cancer (NSCLC) and strategies for tackling osimertinib resistance? Credit available for this activity expires: [07/11/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976634?src=mkm_podcast_addon_976634
More shows like Keeping Current
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
498 Listeners
Diabetes Core Update
102 Listeners
This Week in Cardiology
881 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
26 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
The Curious Clinicians
370 Listeners